| Synonyms: | |
| Status: | Approved (1986) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | A02BA03 |
| UNII: | 5QZO15J2Z8 |
| InChI Key | XUFQPHANEAPEMJ-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C8H15N7O2S3 |
| Molecular Weight | 337.46 |
| AlogP | -0.77 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 175.83 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 20.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Histamine H2 receptor antagonist | DailyMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Lyase
|
- | - | - | 126 | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Histamine receptor
|
- | 300 | 18-100 | - | 87 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 87 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 10700 | - | - | 14 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC47 family of multidrug and toxin extrusion transporters
|
- | 36200 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Gastroesophageal Reflux | 4 | D005764 | ClinicalTrials |
| Stomach Ulcer | 4 | D013276 | ClinicalTrials |
| Ulcer | 4 | D014456 | ClinicalTrials |
| Gastrointestinal Hemorrhage | 3 | D006471 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
| Breast Carcinoma In Situ | 2 | D000071960 | ClinicalTrials |
| Movement Disorders | 2 | D009069 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Immunoglobulin G4-Related Disease | 2 | D000077733 | ClinicalTrials |
| Eosinophilic Esophagitis | 2 | D057765 | ClinicalTrials |
| Schizophrenia | 2 | D012559 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Thyroid Neoplasms | 1 | D013964 | ClinicalTrials |
| HIV Infections | 1 | D015658 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Fibrosis | 1 | D005355 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Anemia, Hemolytic, Autoimmune | 1 | D000744 | ClinicalTrials |
| Psoriasis | 1 | D011565 | ClinicalTrials |
| HIV Infections | 1 | D015658 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 4975 |
| ChEMBL | CHEMBL902 |
| DrugBank | DB00927 |
| DrugCentral | 1129 |
| EPA CompTox | DTXSID5023039 |
| FDA SRS | 5QZO15J2Z8 |
| Human Metabolome Database | HMDB0001919 |
| Guide to Pharmacology | 7074 |
| PharmGKB | PA449586 |
| SureChEMBL | SCHEMBL972 |
| ZINC | ZINC000001530636 |